Abbott Sues Sun Pharma Again Over Generic Niaspan

Law360, New York (February 16, 2010, 6:26 PM EST) -- Abbott Laboratories on Tuesday sued Mumbai-based Sun Pharmaceutical Industries Ltd. and two subsidiaries for the second time in a week, in an effort to prevent the generics maker from releasing its own version of cholesterol drug Niaspan.

The pharmaceutical giant filed a complaint in the U.S. District Court for the Eastern District of Michigan, alleging that plans by Sun; its United Arab Emirates-based subsidiary Sun Pharma Global FZE; and its Michigan-based subsidiary, which shares the same name as its parent, to market a generic version of...
To view the full article, register now.